Lord Blackheath Surfaces Again…But This Time It’s Not…


Source: GizaDeathStar.com
Dr. Joseph P. Farrell Ph.D.
July 31, 2017

All of you remember Lord James of Blackheath, don’t you? Well, in case you’ve forgotten who he is, he was the British peer who, a few years ago, stood in the House of Lords and gave a most peculiar speech that cited unusual amounts of gold in the world. I wrote about his speech – which was causing something of a minor fuss on the internet at that time – in my book Covert Wars and Breakaway Civilizations. In fact, I cited much of his remarks, as Hansard reported them, in that book. The upshot of Lord Blackheath’s remarks was that he was trying to get to the bottom of how much gold there was in the world, and as a result, contacted acquaintances in the Old Lady of Threadneedle Street (the Bank of England), and was given answers that amounted to approximately 1500 tons. There was, of course, much more to Lord Blackheath’s remarks than just that, but that was one of the things that grabbed my attention, for at around the same time, the calls within Germany by Germans to audit their country’s gold reserves had reached such a pitch that the Bundesbank decided to begin the process of repratriation of Germany’s gold deposits from London, Paris, and most importantly, the Federal Reserve Bank of New York. Of course, I don’t for a moment assume these pressures were the only reason Germany decided to do this. If anything, they were convenient pressures, when the real reasons were probably geopolitical, and growing mistrust between Berlin on the one hand, and London and Washington on the other.

In any case, the amounts being cited by Lord Blackheath were far below even the reported amounts of just German gold allegedly on deposit in New York. And of course, Lord Blackheath himself expressed no considerable mystification at the time at not being able to get any rational approximation from his contacts.

Well, Mr. J.R. found this article and passed it along, and I regard it as so significant in terms of my “high octane speculations” about hidden systems of finance, that I absolutely have to comment on it. Here’s the article:

Lord James of Blackheath: I Helped Smuggle Children Used For Slavery And Sex

Now, much as I’d like to belabor the moral myopia of helping to smuggle children out of the United Kingdom when one suspects “something might be going on but I did it anyway,” I suspect the article itself does a decent enough job of that.

So I will pass on to my high octane speculation of the day by way of a bit more background: my friend and colleague, former Assistant Secretary of Housing and Urban development Catherine Austin Fitts has expressed the opinion – during an interview with Daniel Liszt, a.k.a. the “Dark Journalist” – that the western elites have always admired slavery as a system of economic privilege and control. The problem, she averred, was that the capital could not be “perfected,” after all, slaves ran away to pursue a life of freedom and their own economic self interest. Now, however, the means of “perfecting the capital” are available, as the following article suggests:

Wisconsin Company to Implant Microchips in Employees

Most of us, I’m quite certain, who read the second article will have a “John of Patmos moment” contemplating the dire implications of that development.

But if one is running covert human trafficking rings – whether for child sex slavery, adult sex slavery, or other forms of slavery – such technology does allow one to “keep track of the cargo,” i.e., to perfect the “capital.”

Which brings me chin-to-chin with my…

…High Octane Speculation of the day: For years, in several books, blogs, and interviews, I’ve maintained that there is in existence a hidden system of finance, whose basic “mechanics” is the trade in bearer securities backed by “gold”, and hence, for me, I am of the opinion that the various “bearer bond scandals” are not, in spite of all official protestations to the contrary, easily dismissible as “simple counterfeiting scams.” We are assured – at one time even by President Obama himself – that the “securitiesrecovered during these scandals are completely fake, and that there is absolutely nothing to it. Yet, the same scam is run repeatedly, over and over. As I’ve observed several times: “one does not counterfeit a seven dollar bill.” In other words, even if the “securities” recovered during these scandals are fakes, no counterfeiter would attempt to run the same scam over and over again, unless there was an element of truth lurking somewhere in the center of it. The fact that many of these “securities” are “gold-backed” bearer bonds, takes us back once again to lord Blackheath’s mystification a few years ago on the floor of the House of Lords, as recorded in Hansard’s. My argument then was, in order to make a hidden system of finance work, and remain off the books, one key mechanism was the physical movement of such “securities.”

Further research, however, revealed something else, namely, that the term “gold” often functioned as a codename for drugs, and given the overwhelming size of the underground drug economy as a proportion of the financial system, I also concluded that the “gold” backing these “securities” may not have been exclusively actual bullion, but drugs.

In recent years, however, we’ve seen an increase of stories about human trafficking and sex-slavery rings, involving every demographic from little children to Siamese women. The extent of these stories has touched every continent, implying that there are world-wide networks involved in this “business,” which, given its vast extent, must also comprise an underground economy of considerable size. The Taken series of movies with Irish actor Liam Neeson explores this brutal system in fictional guise. The political purpose of such networks is, of course, rather obvious, for it entangles the rich and politically powerful in compromising activity, which create what Catherine Fitts has described as “control files” to blackmail compliance. With this possibility, one is looking at the implication that such rings are deeply and intimately entangled with the “deep state” and various intelligence agencies, and thus, with my hypothesized hidden system of finance.

Which brings me back to Lord Blackheath, and a final, new, speculation. What if “gold” is code not only for “drugs,” but for human “cargo” and “capital”, as part of this enormous network? In other words, what if slavery itself is a crucial component of this hidden system of finance? Need laborers to help build all those underground secret installations? If that sounds far-fetched, don’t forget that there’s precedent: the Nazis did it, and incidentally, they did it within an economic empire being run by the SS, where every unfortunate victim was tagged, tattooed, and numbered as the “capital assets” of the system.

Such a speculation goes a long way, for example, to explain the difficulties facing Vatican bank reform attempts, for if my speculation be true, then that bank would be intimately connected to these “financial activities,” and hence, attempts to deal with clergy scandal abuses and Vatican financial reform are not two separate issues, but intimately connected. Just recently, George

Cardinal Pell, who was tasked by Pope Francis to oversee the Vatican budget, has returned to Australia to answer sexual abuse charges.

However, if what I am proposing is true, then the extent of this human trafficking-finance ring will not be confined solely or exclusively to the Vatican: it will be intimately entwined with other large financial institutions. The Vatican might just end up being the (convenient) patsy. The hypothesis might even go a long way to explain one possible reason behind all the mysterious banker deaths and “suicides” of the past few years.

See you on the flip side..

Read More At: GizaDeathStar.com
________________________________________________

About Dr. Joseph P. Farrell

Joseph P. Farrell has a doctorate in patristics from the University of Oxford, and pursues research in physics, alternative history and science, and “strange stuff”. His book The Giza DeathStar, for which the Giza Community is named, was published in the spring of 2002, and was his first venture into “alternative history and science”.

Advertisements

Why Pharmaceuticals Are Really The “Alternative Medicine”

Why Pharmaceuticals Are Really The
Source: GreenMedInfo.com
Sayer Ji
May 20, 2017

Did you know that natural medicine was once, and still is, the default medical system on this planet?

In fact, the use of synthetically produced patent medicines (pharmaceuticals) is a relatively recent development (circa 1870), and should really be called the “alternative medicine” vis-a-vis time-tested, far safer approaches that rely on food, spices, and carefully prepared and administered plant extracts.


A powerful new report released by the Kew Gardens in the United Kingdom reveals that there are currently 28,187 plant species recorded as being of medicinal use throughout the world. In addition, the report revealed that fewer than 16% (4,478) of the species used in plant-based medicines are cited in a medicinal regulatory publication.

While the lesser developed countries are the primary users of plant medicines, they are used in great abundance throughout the world. Even in countries like Germany where conventional, drug-based medicine is the default approach, about 90% of their population also uses herbal medicines. Even the most pharmaceutically obsessed country in the world, the United States, spent 17 billion dollars on traditional herbal medicines in 2000 alone, and the number has grown steadily since then.

It should be noted that mixing plant-based medicines with pharmaceuticals can be dangerous, and as the report points out, many of these plants contain compounds that can cause harm if taken incorrectly. There is also a problem with misnaming or multiple names for the same plant-based medicines::

“143 DATABASES AND PUBLICATIONS CITE 415,180 UNIQUE NAMES FOR PLANT-BASED MEDICINES– AN AVERAGE OF 15 ALTERNATIVE NAMES FOR EACH SPECIES.”

The report also pointed out that…

Read More At: GreenMedInfo.com

Prescription drugs declared “one of the most significant perils to human health” by British medical journal

Image: Prescription drugs declared “one of the most significant perils to human health” by British medical journal
Source: NaturalNews.com
Earl Garcia
March 16, 2017

Prescription drug therapy has been a major contributor to the soaring rates of serious, disabling or fatal injuries, according to a 2011 study published in the British Journal of Medicine. Data from the Institute for Safe Medication Practices showed that anticoagulants dabigatran and warfarin were the most frequently identified medications that were reported to the FDA, suggesting that treatments designed to inhibit blood clots top the health risk index among prescription drugs. Nine other drugs were also shown to meet five criteria for clinically-relevant injuries associated with drugs.

The FDA received a total of 179,855 reports of serious, disabling and fatal drug interactions in the U.S. in 2011, a significant 9.4 percent increase (15,386 more cases) from 2010. The federal agency received the highest number of direct calls for the anticoagulants dabigatran and warfarin at 817 and 490, respectively.

Dabigatran was approved in 2010 for the prevention of stroke among patients with atrial fibrillation. Both manufacturer and direct FDA reports showed that the prescription drug was associated with nearly 4,000 serious domestic health conditions in 2011, surpassing many other regularly monitored prescription drugs. Dabigatran was the most commonly reported anticoagulant for hemorrhage, acute renal failure, stroke and liver failure.

Warfarin, on the other hand, is a generic drug that was approved in 1954, and has since become a staple in anticoagulation therapy. The generic prescription drug accounted for 1,106 reports in 2011, including 72 deaths. Warfarin requires regular laboratory assessment to optimize dosing. It also interacts with numerous other treatments.

Other prescription drugs listed were levofloxacin, carboplatin and lisinopril. These prescription drugs each accounted for more than 300 direct reports to the FDA.

Various prescription drugs were also attributed to many direct FDA reports regarding lawsuits filed by injured patients. Metoclopramide tops the list with 11,450 cases filed against its manufacturer. Metoclopramide is used in the treatment of acid reflux and nausea. The drug is tied to irreversible movement disorders.

Oral contraceptives Yaz and Yasmin were hit by 8,354 lawsuits in 2011. The drugs contain synthetic progestin, and are linked to higher odds of blood clots.

Avandia, a type 2 diabetes drug, had a total of 4,105 cases filed against its manufacturer. Avandia has been tied to increased risk of cardiovascular disease among patients with diabetes.

Chantix was fourth among the most sued drugs. Chantix is a smoking cessation drug associated with serious psychiatric side effects.

Accutane, a prescription drug used for the treatment of severe acne, contains strong warnings about inflammatory bowel disease, pancreatitis, serious skin conditions, birth defects and psychiatric disorders.

Data show the most reported side effects and notorious drugs behind them

Researchers identified that severe liver injury was the most prominent side effect associated with prescription drug therapy. A total of 2,260 such injuries were reported in 2011. Infliximab and acetaminophen accounted for 13.2 percent of reported cases. Data showed that infliximab led to a total of 159 reported cases, while acetaminophen accounted for 139 cases.

Severe cutaneous reactions appeared to be the second most reported adverse events at 2,207 cases. Severe skin reactions resulting from taking prescription drugs were noted in the report. Some serious cases involved life threatening skin conditions like Stevens-Johnson syndrome and Toxic Epidermal Necrolysis. Lamotrigine, an anti-epileptic drug, was linked to most reported cases at 119, followed by smoking cessation treatment, Chantix, at 93 cases. Both drugs were responsible for 9.6 percent of reported cases of severe cutaneous reactions.

Data also revealed that suicidal and/or homicidal tendencies were listed among the most prominent side effects of prescription drug treatment. According to the report, a total of 2,030 cases of suicidal/homicidal attempts were tied to prescription therapy in 2011. Quetiapine, a drug used to treat psychosis, ranked as the leading drug suspect for suicidal/homicidal attempts, at 197 reported cases. The smoking cessation drug varenicline accounted for 187 cases.

Pancreatitis was also a prominent side effect that was tied to prescription medications. According to the report, there were nearly 2,000 reported cases of pancreatitis in 2011. Diabetes drugs liraglutide and exenatide were attributed to 43 percent of pancreatitis cases reported. Liraglutide accounted for 413 reported cases of pancreatitis, while exenatide was blamed for 404 cases.

Rhabdomyolysis was also included in the list of most reported side effects. This condition occurs when damaged or destroyed skeletal muscle cells release a protein called myoglobin into the bloodstream. High myoglobin levels lead to renal failure. More than 500 cases of rhabdolyolysis were associated with prescription drug treatment. Cholesterol-lowering drugs simvastatin and rosuvastatin accounted for a 38 percent incidence rate in the report, at 123 cases and 73 cases, respectively.

Big Pharma: From Rx blunders to billion dollar revenues

The U.S. pharmaceutical industry plays a vital role in global drug production. Data from statistics portal STATISTA shows that the U.S. alone is responsible for more than 40 percent of the total global pharmaceutical market. In fact, this share was estimated to have a net value of about $413 billion in 2015. In the same year, six of the top 11 global drug firms were based in the U.S.

Johnson & Johnson, Pfizer and Merck & Co. were the largest U.S.-based drug firms in the global market. Johnson and & Johnson alone generated around $70 billion in revenue for F.Y. 2015.

Statistics also showed that the total nominal drug spend in the country amounted to $425 billion in 2015. Diabetes, cancer and autoimmune disorders were among the top three conditions that a large chunk of money was being spent on. The U.S. spent more than $110 million on these diseases in 2015 alone. On the other hand, Gilead Sciences’ hepatitis C drug, Harvoni, was the highest-selling treatment in the U.S., generating a massive revenue of close to $14 billion in 2015.

According to a report by the Centre for Research on Globalization, more than 75 percent of U.S. citizens aged 50 and older are currently taking prescription medicines, while one-in-four middle-aged women are reportedly on antidepressants. Research also shows that the U.S. consumes up to 80 percent of the global supply of painkillers. People who admit to taking prescription drugs report taking four prescription treatments on a daily basis.

The report also identified medical error as a third leading cause of death in the U.S. – well behind heart disease and cancer. Data showed that 440,000 U.S. citizens die annually due to medical errors that are otherwise preventable. Heavy reliance on big pharmaceutical companies for drug information appears to be the root cause of misdiagnosis and subsequent medical errors committed by medical practitioners. Their lack of adequate knowledge and training on certain drug interactions contributes to the increasing rates of medical errors that could have been prevented. Furthermore, the report states that the over-prescription of antibiotics has proved to be a rising threat in the U.S., with up to 20,000 prescriptions released every year. Most of these antibiotics contain toxic chemicals that can cause severe damage to the nervous system.

Mismanagement of antibiotic intake has been shown to promote bacterial resistance, making the drugs less effective. The report argues that doctors and big pharmaceutical companies know this, but continue to push the over-prescription of antibiotics anyway. The report also called out the big pharma industry, stating that the inclusion of various toxins and questionable ingredients in childhood vaccines is egregious in nature and further exacerbates the risk of autism, brain damage and death.

Follow more news about the dangers of today’s medical drug cartels at DrugCartels.news.

Read More At: NaturalNews.com

Sources: 

OMSJ.org[PDF]

Statista.com

GlobalResearch.ca

The CIA & the Drug Trade

Source: CorbettReportExtras
James Corbett
February 10, 2017

TRANSCRIPT AND SOURCES: https://www.corbettreport.com/?p=2831

NOTE: This video was produced for BoilingFrogsPost.com on October 14, 2011. It is being made available in its entirety here for the first time.

Just as the British Empire was in part financed by their control of the opium trade through the British East India Company, so too has the CIA been found time after time to be at the heart of the modern international drug trade. From its very inception, the CIA has been embroiled in the murky underworld of drug trafficking.

There are billions of dollars per year to be made in keeping the drug trade going, and it has long been established that Wall Street and the major American banks rely on drug money as a ready source of liquid capital. With those kinds of funds at stake, it is unsurprising to see a media-government-banking nexus develop around the status quo of a never-ending war on drugs – aided, abetted and facilitated by the modern-day British East India Company, the CIA.

This is our EyeOpener Report by James Corbett presenting the history, documented facts, and cases on the CIA’s involvement and operations in the underworld of drug trafficking, from the Corsican Mafia in the 1940s through the 1980s Contras to the recent Zambada Niebla Case today.

Pharma Companies Spend 19x more on Marketing than Research, and Returns are Dropping

Drug prices are going up while R&D spending is going down

money-pills-pharma-spend-735-295
Source: NaturalSociety.com
Christina Sarich
December 21, 2016

The pharmaceutical industry swears the high cost of drugs is due to research and development costs, conveniently omitting the actual amount of money spent on the marketing of these drugs, which is exorbitantly more. A recent Deloitte report suggests that pharmaceutical companies are taking a hit because investments made in R&D on new drugs simply are not paying off anymore. [1]

image-pharma-money-marketing

As we previously reported, pharmaceutical companies spend more money on marketing drugs than research and development. Johnson & Johnson for example recently spent $17.5 billion on marketing and only $8.2 billion on research and development. Similarly Pfizer spent $11.4 billion on marketing and only $6.6 billion on research and development. [2]

Deloitte’s research into a total of 12 pharmaceutical companies’ R&D expenditures for the previous year is telling, even though the comparatively small amount of money spent on R&D isn’t paying off for Big Pharma like it used to.

According to the Pew Charitable Trusts, more than $27 billion was spent on marketing to physicians by the pharmaceutical industry in the year 2012. You can do a search to find out if your doctor has been taking money from Big Pharma.

Read: Composing Only 5% of the World Population, Americans Take 50% of All Pharmaceutical Drugs

As reported by BusinessInsider:

“In 2010 Deloitte began following the top 12 pharmaceutical companies by R&D (or research and development) spending recorded the previous year. This 12-company cohort has since launched 186 products with estimated total revenue of $1.258 trillion, and it has collectively advanced 306 drug candidates with total forecast lifetime revenue of $1.414 trillion into late-stage development.” [1]

Though these figures are eye-popping, returns on R&D are a tiny 4.2% compared to the baseline of 10.1% observed in more recent years.

Returns have also been lower every year with the exception of 2014. There could be multiple factors causing the drop in returns, but sales forecasts have fallen by 50% to $416 million per year while development costs per drug have increased by 33%.

According to a report in BMJ, prescription drug companies aren’t putting a lot of resources toward new, groundbreaking medications, because it simply isn’t paying off. As outlined by the study authors, it seems that it is more profitable for the company to create variations of products that are already on the market.

“[P]harmaceutical research and development turns out mostly minor variations on existing drugs,” the authors write. “Sales from these drugs generate steady profits throughout the ups and downs of blockbusters coming off patents.”

The authors say that for every $1 pharmaceutical companies spend on “basic research,” $19 goes toward marketing and promotion.

What’s more, drug makers are also facing more stringent reviews of their drugs once they go to market. For example, GlaxoSmithKline was recently hit with analysis from the U.S. budget watchdog, the Institute for Clinical and Economic Review, which found Glaxo’s new severe asthma therapy Nucala is overpriced by 63% or more.

The loss of billions in R&D returns in a trillion dollar industry is likely also the reason many companies promote off-label drug use and push clinical trials through the FDA using what is likely their own biased research.

Read More At: NaturalNews.com

Source:

[1] Business Insider

[2] The Huffington Post


Breaking: Bayer buys Monsanto: the Empire strikes back

QuestionEverything
Source: NoMoreFakeNews.com
Jon Rappoport
September 16, 2016

This is the largest corporate cash buyout in history.

Mega-giant Bayer put $66 billion on the table, and mega-giant Monsanto said yes.

Think GMOs, crop seeds, pesticides, medical drugs.

Keep in mind that one of the consultants on the European side of this deal is the Rothschild Group.

But that’s not all. Dow and DuPont are planning to merge. Recently, another biotech giant, Syngenta, was swallowed up by the state-owned ChemChina. And this just in: two major Canadian fertilizer manufacturers, Potash Corp of Saskatchewan Inc. and Agrium Inc. are merging.

Consolidation, monopoly. The Empire strikes back.

The global rebellion against GMOs and pesticides, particularly Monsanto’s Roundup, is one of the reasons for these deals. But lurking in the background is another factor, exemplified by the pending Trans-Pacific Partnership (TPP) treaty.

If the TPP passes, corporate tribunals will take over the adjudication of disputes in which a nation rejects importing toxic pesticides, medical drugs, or GMOs. These tribunals will decide whether that nation is permitted to refuse importation.

Of course, the tribunals will favor mega-corporate interests. But now, with the mergers involving Bayer, Monsanto, Dow, DuPont, Syngenta, and ChemChina, the devastating clout of the tribunals will be that much more powerful.

The ability to shove toxic products down the throats of populations will elevate.

This is the corporate face of Globalism.

This is a giant step in the direction of controlling the world’s food supply.

Continue Reading At: JonRappoport.wordpress.com
________________________________________________________________

Jon Rappoport

The author of three explosive collections, THE MATRIX REVEALED, EXIT FROM THE MATRIX, and POWER OUTSIDE THE MATRIX, Jon was a candidate for a US Congressional seat in the 29th District of California. He maintains a consulting practice for private clients, the purpose of which is the expansion of personal creative power. Nominated for a Pulitzer Prize, he has worked as an investigative reporter for 30 years, writing articles on politics, medicine, and health for CBS Healthwatch, LA Weekly, Spin Magazine, Stern, and other newspapers and magazines in the US and Europe. Jon has delivered lectures and seminars on global politics, health, logic, and creative power to audiences around the world. You can sign up for his free NoMoreFakeNews emails here or his free OutsideTheRealityMachine emails here.

You’re Kidding…ANOTHER Bearer Bond Scandal…In…

 YOU’RE KIDDING… ANOTHER BEARER BONDS SCANDAL… IN ...
Source: GizaDeathStar.com
Dr. Joseph P. Farrell
August 28, 2016

Just when you thought we were done with all those bearer bonds scandals and  that they were a thing of the past, or at least, being carefully covered up, they surface again, this time in Florida, according to this article shared by Ms. P.H.:

Billion-dollar bond that man tried to cash in Broward was fake, feds say

Now, if you’re familiar with these bearer bond stories, you’ll have noted a number of departures from the standard “pattern”:

The bond, supposedly issued in 1934, appears to have been printed on an inkjet printer and seemed to contain a security thread – both technologies that did not exist until many years later, investigators said. The counterfeit bond also featured a photograph of Grover Cleveland, who was president in the 1880s and 1890s.

But perhaps the biggest clue was the eye-popping billion-dollar figure on the face of the bond. U.S. Secret Service Agent Charles Callahan told a judge Wednesday in federal court in Fort Lauderdale that the highest-valued bearer bond in that era was $10,000 and the highest-valued bond ever was a $1 million one issued in 1978.

Hugo Barrios Briceno, the 50-year-old Venezuelan man accused of trying to cash the counterfeit bond at a Fort Lauderdale financial business earlier this month, will remain locked up because he is a potential flight risk, U.S. Magistrate Judge Patrick Hunt ruled Wednesday. Barrios Briceno was arrested Aug. 16.

Note what we have in terms of the “bearer bonds pattern” according to the above paragraphs:

1)  a bond “issued” in 1934: this does fit the pattern which has been seen before, with the so-called 1934 “Morgenthau” bonds, allegedly issued by the US Federal Reserve System(not the US Treasury) to elements of the Khoumintang government of Chiang Kai-Shek in return for the fed’s storage of Nationalist Chinese gold. Note what this means: for if these bonds ever surfaced, the US Treasury, since it did not issue them, can claim they are fake, and that it has no knowledge of them. Morgenthau was the then US Secretary of the Treasury under President Franklin Roosevelt. On the so-called 1934 “Morgenthau’s”, the signature of Secretary Morgenthau does appear to be the authentic signature such as it appeared on US currency at the time.

2) the “bond” was printed on an ink jet printer and contained a security thread: this both does and does not fit the pattern of previous bearer bond stories, for in some versions of other bearer bonds stories, the “bonds” appear to have been lithographed, and not printed with the intaglio method typical of official US currency and securities at that time. What is odd – genuinely odd – here is that the bond contained a “security thread,” which raises the important question of why the counterfeiters of this bond went to all the trouble to procure paper with this feature. It can be done, of course, but doing so would  be bound to raise suspicion from any legitimate vendor. Perhaps such features are typical of  US (or other nations’) bearer bonds and thus the counterfeiters had to reproduce it. There are other possibilities, of course, but we’ll get to those in our high octane speculation.

3) The “bond” was issued with a picture of Grover Cleveland: This does fit the pattern of the bearer bonds, for in almost all versions of their occurrence, actual US currency issues were used as the “donor document” to create the “counterfeit” bonds, and since Grover Cleveland appeared on the one thousand dollar US Gold certificate, it is no problem to add a few extra zeros and create an entirely new denominated currency or security. Indeed, some people have already transformed the Cleveland one thousand dollar bill into a one million dollar bill (see Cleveland one million dollar bills). Indeed, we’ve seen bearer bonds with the pictures of George Washington and Woodrow Wilson, both borrowed from the US Currency issues bearing their likeness. The only president on a bearer bond who has never appeared on an issue of US currency was John F. Kennedy.

4) The highest denomination of bearer bond ca. 1934 was $10,000 and the highest ever denomination was $1000,000: this is where we run into trouble, for if I recall correctly, during the Italian bearer bonds scandal that apprehended two Japanese men carrying $134,500,000,000 in allegedly counterfeit bills, during this scandal, the US government denied that bonds of one billion dollars had ever been issued, but left the problem of $500,000,000 bearer bonds unsettled. Again, it is important to note that, as far as the Treasury is concerned, this is entirely true, since most bearer bonds – and especially the 1934 “Morgenthaus” – were allegedly issued by the Federal Reserve.

So what might we be looking at here?

Indulge my high octane speculation once again, for I think we’re looking at something real, and perhaps even at a real bond. Note this unusual thing about the story:

Defense lawyer Alberto Quirantes said his client committed no crime and was tricked into repeatedly trying to cash the bond. He said Barrios Briceno believed the bond was genuine, based on advice from at least two people he thought were experts.

“Somebody duped him,” Quirantes told the judge. “This is a complete shock to this man.”

The prosecutor said the investigation began after a financial adviser in Fort Lauderdale reported Barrios Briceno, a Venezuelan resident who was visiting South Florida on a business visa, had contacted him about cashing the bond.

Barrios Briceno said the bond belonged to someone he knew in Bogota, Colombia, according to court records. He said he wanted to deposit $500 million from the bond into his bank account and open an investment account with the other $500 million from the bond, agents said.

The Secret Service arranged for an agent to pose undercover as a worker who would help the financial adviser to liquidate the bond at an Aug. 16 meeting, which was secretly audio- and video-recorded, authorities said.

Prosecutors said that the bond would have an equivalent value of 19 billion dollars in today’s currency. They also said that a simple Google search would have shown Barrios Briceno that billion-dollar bonds are not legitimate.

If convicted, he could face as much as 15 ½ to 19 ½ years in federal prison, based on the face value of the counterfeit bond, prosecutors said.

According to the Secret Service, Barrios Briceno said that his contact in Colombia gave a loan to someone who provided the bond as collateral but never repaid the debt. The lender then asked Barrios Briceno to try to cash the bond, which he said he picked up from the lender’s sister in late June at Miami International Airport.

Barrios Briceno told agents he had picked it up at the airport because he was concerned that customs officials would question him about it.

The defense said in court that Barrios Briceno went to Washington, D.C., in early August and met with someone who “verified” the bond was valid for a fee of about $30,000. Barrios Briceno also said he met separately with representatives from four major financial institutions and that one of them offered $180 million for the bond. The lawyer said nobody gave his client any reason to think the bond was counterfeit.
(emphasis added)

So what do we have? We have:

1) A South American, Columbian businessman;

2) in the USA on a business visa;

3) who paid $30,000 in fees to “validate” the bond. Pause for a moment and consider what this means: it means that there are so many such bearers bonds, that this story is so regularly occurring, even if not reported, that the story now has “experts” validating bonds!

4) Barrios Briceno, the “accused” Columbian businessman, states that he had received offers from “four major financial institutions”, one of which offered to buy the bond at a discount. If true (and I suspect it is), then why would any “major financial institution” buy a counterfeit bond that isn’t worth the paper and ink it took to make it? And finally…

Continue Reading At: GizaDeathStar.com
________________________________________________________________

Profile photo of Joseph P. Farrell
Joseph P. Farrell has a doctorate in patristics from the University of Oxford, and pursues research in physics, alternative history and science, and “strange stuff”. His book The Giza DeathStar, for which the Giza Community is named, was published in the spring of 2002, and was his first venture into “alternative history and science”.